Ex Vivo Production of Platelets From iPSCs: The iPLAT1 Study and Beyond

Ex Vivo Production of Platelets From iPSCs: The iPLAT1 Study and Beyond

Bibliographic Details
Main Authors:	Naoshi Sugimoto, Koji Eto
Format:	Article
Language:	English
Published:	Wiley 2023-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/HS9.0000000000000884

Similar Items

Ex vivo generation of platelet products from human iPS cells
by: Sou Nakamura, et al.
Published: (2020-12-01)

iPSCs are safe!
by: Hualong Yan, et al.
Published: (2017-05-01)

Mass production of iPSC-derived platelets toward the clinical application
by: Akihiro Kayama, et al.
Published: (2024-03-01)

Targeted Integration of Inducible Caspase-9 in Human iPSCs Allows Efficient <i>in vitro</i> Clearance of iPSCs and iPSC-Macrophages
by: Alexandra Lipus, et al.
Published: (2020-04-01)

iPSCs in Modeling and Therapy of Osteoarthritis
by: Maria Csobonyeiova, et al.
Published: (2021-02-01)

Phenotyping Neurodegeneration in Human iPSCs
by: Li, Jonathan, et al.
Published: (2021)

Applications of iPSCs in Cancer Research
by: Jean J. Kim
Published: (2015-01-01)

Applications of iPSCs in Cancer Research
by: Jean J. Kim
Published: (2015-07-01)

Parallel derivation of X-monosomy induced pluripotent stem cells (iPSCs) with isogenic control iPSCs
by: Anis Feki, et al.
Published: (2020-08-01)

Differentiation of human iPSCs into functional podocytes.
by: Caroline Rauch, et al.
Published: (2018-01-01)

Transplantation of mouse iPSCs into testis of azoospermic mouse model: in vivo and in vitro study
by: Forouzan Rahmani, et al.
Published: (2019-12-01)

Identification of cell-biologic mechanisms of coronary artery spasm and its ex vivo diagnosis using peripheral blood-derived iPSCs
by: Han-Mo Yang, et al.
Published: (2023-02-01)

Broader Implications of Defining Standards for the Pluripotency of iPSCs
by: Daley, George Q., et al.
Published: (2015)

Modelling urea cycle disorders using iPSCs
by: Claire Duff, et al.
Published: (2022-09-01)

MSCs vs. iPSCs: Potential in therapeutic applications
by: Kalaiselvaan Thanaskody, et al.
Published: (2022-11-01)

Nanog-Independent Reprogramming to iPSCs with Canonical Factors
by: Ava C. Carter, et al.
Published: (2014-02-01)

Disease, iPSCs and a Quest for the Perfect Model
Published: (2016-02-01)

iPSCs in NK Cell Manufacturing and NKEV Development
by: Nicholas Boyd-Gibbins, et al.
Published: (2022-07-01)

Deficiency in MT5-MMP Supports Branching of Human iPSCs-Derived Neurons and Reduces Expression of GLAST/S100 in iPSCs-Derived Astrocytes
by: Nikita Arnst, et al.
Published: (2021-07-01)

Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies
by: Suman C. Nath, et al.
Published: (2023-11-01)

iPSCs and Exosomes: Partners in Crime Fighting Cardiovascular Diseases
by: Giulia Germena, et al.
Published: (2021-06-01)

The Defects of Epigenetic Reprogramming in Dox-Dependent Porcine-iPSCs
by: Aiwen Jiang, et al.
Published: (2022-10-01)

Protocol for Differentiation of Human iPSCs into Pulmonary Neuroendocrine Cells
by: Pooja Hor, et al.
Published: (2020-09-01)

Microhomology-assisted scarless genome editing in human iPSCs
by: Shin-Il Kim, et al.
Published: (2018-03-01)

Pannexin 1 Influences Lineage Specification of Human iPSCs
by: Rebecca J. Noort, et al.
Published: (2021-04-01)

Breakthrough in large-scale production of iPSCs-derived exosomes to promote clinical applications
by: Xiaoxiao Chen, et al.
Published: (2023-08-01)

iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity
by: Daisuke Suzuki, et al.
Published: (2020-01-01)

Manipulation of KLF4 Expression Generates iPSCs Paused at Successive Stages of Reprogramming
by: Ken Nishimura, et al.
Published: (2014-11-01)

Modeling Glanzmann thrombasthenia using patient specific iPSCs and restoring platelet aggregation function by CD41 overexpression
by: Liang Hu, et al.
Published: (2017-04-01)

Antisense Oligonucleotides Reduce RNA Foci in Spinocerebellar Ataxia 36 Patient iPSCs
by: Kosuke Matsuzono, et al.
Published: (2017-09-01)

Derivation and molecular characterization of pancreatic differentiated MODY1-iPSCs
by: Braverman-Gross, C, et al.
Published: (2018)

Modelling Takenouchi-Kosaki syndrome using disease-specific iPSCs
by: Suganya Thanasegaran, et al.
Published: (2023-12-01)

iPSCs: A Preclinical Drug Research Tool for Neurological Disorders
by: Gabriele Bonaventura, et al.
Published: (2021-04-01)

Human iPSCs as Model Systems for BMP-Related Rare Diseases
by: Gonzalo Sánchez-Duffhues, et al.
Published: (2023-09-01)

The Developmental Potential of iPSCs Is Greatly Influenced by Reprogramming Factor Selection
by: Buganim, Yosef, et al.
Published: (2017)

Advances and challenges in modeling inherited peripheral neuropathies using iPSCs
by: Van Lent, J, et al.
Published: (2024)

Corneal cell therapy: with iPSCs, it is no more a far-sight
by: Koushik Chakrabarty, et al.
Published: (2018-10-01)

Recent Overview of the Use of iPSCs Huntington’s Disease Modeling and Therapy
by: Maria Csobonyeiova, et al.
Published: (2020-03-01)

Subtype-Directed Differentiation of Human iPSCs into Atrial and Ventricular Cardiomyocytes
by: Mandy Kleinsorge, et al.
Published: (2020-06-01)

Derivation and molecular characterization of pancreatic differentiated MODY1-iPSCs
by: Carmel Braverman-Gross, et al.
Published: (2018-08-01)